Literature DB >> 16758192

Primary hepatic invasive aspergillosis with progression after rituximab therapy for a post transplantation lymphoproliferative disorder.

W J F M van der Velden, N M A Blijlevens, R R Klont, J P Donnelly, P E Verweij.   

Abstract

We present a case of primary hepatic and possible splenic invasive aspergillosis (IA), which progressed under anti-CD20 B cell treatment for posttransplantation lymphoproliferative disease following allogeneic stem cell transplantation, to highlight the clinical value of a positive galactomannan-antigen test, an intestinal portal of entry of Aspergillus, and the detrimental effect of B lymphocyte depletion in IA.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16758192     DOI： 10.1007/s00277-006-0129-x

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


  10 in total

Review 1.  Does rituximab increase the incidence of infectious complications? A narrative review.

Authors:  Theodoros Kelesidis; George Daikos; Dimitrios Boumpas; Sotirios Tsiodras
Journal:  Int J Infect Dis       Date:  2010-11-11       Impact factor: 3.623

2.  Successful treatment of Aspergillus liver abscesses in a patient with acute monoblastic leukemia using combination antifungal therapy including micafungin as a key drug.

Authors:  Rie Yamada; Kentaro Horikawa; Sonoko Ishihara; Koyu Hoshino; Tatsuya Kawaguchi; Ken-ichi Iyama; Hiroaki Mitsuya; Norio Asou
Journal:  Int J Hematol       Date:  2010-03-30       Impact factor: 2.490

Review 3.  The protective role of immunoglobulins in fungal infections and inflammation.

Authors:  Sri Ramulu Elluru; Srini V Kaveri; Jagadeesh Bayry
Journal:  Semin Immunopathol       Date:  2014-11-18       Impact factor: 9.623

4.  Assessment of Aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis.

Authors:  Leonardo Potenza; Patrizia Barozzi; Giulio Rossi; Giovanni Palazzi; Daniela Vallerini; Giovanni Riva; Monica Cellini; Monica Morselli; Francesco Volzone; Claudia Venturelli; Chiara Quadrelli; Luciana Di Pancrazio; Maria Carmen Cano; Paolo Paolucci; Giuseppe Torelli; Mario Luppi
Journal:  Clin Vaccine Immunol       Date:  2008-07-30

5.  Improved detection of circulating Aspergillus antigen by use of a modified pretreatment procedure.

Authors:  Monique A S H Mennink-Kersten; Dorien Ruegebrink; Rocus R Klont; Adilia Warris; Nicole M A Blijlevens; J Peter Donnelly; Paul E Verweij
Journal:  J Clin Microbiol       Date:  2008-02-20       Impact factor: 5.948

6.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

Review 7.  Characteristic clinical features of Aspergillus appendicitis: Case report and literature review.

Authors:  Mihajlo Gjeorgjievski; Mitual B Amin; Mitchell S Cappell
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

8.  Successful treatment of liver aspergilloma by caspofungin acetate first-line therapy in a non-immunocompromised patient.

Authors:  Qing-Xian Bai; Yi Huan; Jian-Hong Wang; Li-Jie Yang; Hong-Juan Dong
Journal:  Int J Mol Sci       Date:  2012-09-06       Impact factor: 6.208

9.  Disseminated Aspergillosis due to Aspergillus niger in Immunocompetent Patient: A Case Report.

Authors:  Ulku Ergene; Zeynep Akcali; Demircan Ozbalci; Nalan Nese; Sebnem Senol
Journal:  Case Rep Infect Dis       Date:  2013-02-28

Review 10.  Liver fungal infections: an overview of the etiology and epidemiology in patients affected or not affected by oncohematologic malignancies.

Authors:  Marco Fiore; Marco Cascella; Sabrina Bimonte; Alberto Enrico Maraolo; Ivan Gentile; Vincenzo Schiavone; Maria Caterina Pace
Journal:  Infect Drug Resist       Date:  2018-01-29       Impact factor: 4.003
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.